MXiPr |
|
| Legal status |
|
|---|
|
2-(isopropylamino)-2-(3-methoxyphenyl)cyclohexan-1-one
|
| CAS Number | |
|---|
| PubChem CID | |
|---|
| UNII | |
|---|
| CompTox Dashboard (EPA) | |
|---|
|
| Formula | C16H23NO2 |
|---|
| Molar mass | 261.365 g·mol−1 |
|---|
| 3D model (JSmol) | |
|---|
CC(C)NC1(CCCCC1=O)c1cccc(OC)c1
|
InChI=1S/C16H23NO2/c1-12(2)17-16(10-5-4-9-15(16)18)13-7-6-8-14(11-13)19-3/h6-8,11-12,17H,4-5,9-10H2,1-3H3 Key:FTQIVDGNGXPEKP-UHFFFAOYSA-N
|
MXiPr (Methoxisopropamine, Isopropyloxetamine, Isopropyxetamine') is a recreational designer drug with dissociative effects. It is an arylcyclohexylamine derivative, related to drugs such as ketamine and methoxetamine. It was first identified in Slovenia in December 2020,[1] and was made illegal in Hungary in April 2021.[2]
See also
References
|
|---|
Psychedelics (5-HT2AR agonists) |
- Tryptamines (e.g., DMT, psilocin, psilocybin, bufotenin, 5-MeO-DMT, AMT)
- Phenethylamines (e.g., mescaline, 2C-B, DOM, MDA, TMA, 2C-B-FLY, 25I-NBOMe)
- Lysergamides (e.g., LSD, ergine, isoergine)
- Others (e.g., quipazine, efavirenz)
- For a full list of serotonergic psychedelics, see the navbox here and the list here instead.
|
|---|
Dissociatives (NMDAR antagonists) | |
|---|
Deliriants (mAChR antagonists) | |
|---|
Cannabinoids (CB1R agonists) | |
|---|
| κOR agonists | |
|---|
| GABAAR agonists | |
|---|
Inhalants (mixed MoATooltip mechanism of action) |
- Aliphatic hydrocarbons
- Butane
- Gasoline
- Kerosene
- Propane
- Aromatic hydrocarbons
- Ethers
- Haloalkanes
|
|---|
| Others |
- Aminochromes (e.g., adrenochrome, adrenolutin)
- Carbogen
- Certain GABAA receptor positive allosteric modulators (nonbenzodiazepines/Z-drugs) (e.g., eszopiclone, zaleplon, zolpidem, zopiclone)
- CI-966
- Cryogenine
- Glaucine
- Hallucinogenic bolete mushrooms (e.g., Lanmaoa asiatica)
- Harmala alkaloids/β-carbolines (e.g., harmaline, 6-methoxyharmalan)
- Iboga alkaloids/azepinoindoles (e.g., ibogaine)
- Isoaminile
- Noscapine
- Nutmeg (e.g., myristicin, elemicin)
- Oneirogens (e.g., Calea zacatechichi, galantamine, nicotine, Silene capensis)
- Prenoxdiazine
- Pukateine
|
|---|
|
|
|---|
|
|---|
| AMPARTooltip α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor | |
|---|
| KARTooltip Kainate receptor | |
|---|
| NMDARTooltip N-Methyl-D-aspartate receptor | |
|---|
- See also: Receptor/signaling modulators
- Metabotropic glutamate receptor modulators
- Glutamate metabolism/transport modulators
|
|
|---|
| Group I | | mGluR1Tooltip Metabotropic glutamate receptor 1 | |
|---|
| mGluR5Tooltip Metabotropic glutamate receptor 5 | |
|---|
|
|---|
| Group II | | mGluR2Tooltip Metabotropic glutamate receptor 2 | |
|---|
| mGluR3Tooltip Metabotropic glutamate receptor 3 | |
|---|
|
|---|
| Group III | | mGluR4Tooltip Metabotropic glutamate receptor 4 |
- Antagonists: CPPG
- MAP4
- MPPG
- MSOP
- MTPG
- UBP-1112
|
|---|
| mGluR6Tooltip Metabotropic glutamate receptor 6 |
- Antagonists: CPPG
- MAP4
- MPPG
- MSOP
- MTPG
- UBP-1112
|
|---|
| mGluR7Tooltip Metabotropic glutamate receptor 7 |
- Antagonists: CPPG
- MAP4
- MMPIP
- MPPG
- MSOP
- MTPG
- UBP-1112
- XAP044; Negative allosteric modulators: ADX71743
|
|---|
| mGluR8Tooltip Metabotropic glutamate receptor 8 |
- Antagonists: CPPG
- MAP4
- MPPG
- MSOP
- MTPG
- UBP-1112
|
|---|
|
|---|
See also: Receptor/signaling modulators • Ionotropic glutamate receptor modulators • Glutamate metabolism/transport modulators |
|
|
|---|
| σ1 | |
|---|
| σ2 | |
|---|
| Unsorted |
- Antagonists: AHD1
- AZ66
- Lamotrigine
- Naloxone
- SM-21
- UMB-100
- UMB-101
- UMB-103
- UMB-116
- YZ-011
- YZ-069
- YZ-185
|
|---|
See also: Receptor/signaling modulators |